| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Departments of Neurology (Drs. Dávalos, Castellanos, Silva, and Serena) and Neuroradiology (Dr. Pedraza), Hospital Universitari Doctor Josep Trueta, Girona, and Departments of Neurology (Drs. Blanco, Leiera, and Castillo) and Neuroradiology (Dr. Pumar), Hospital Clínico Universitario, Santiago de Compostela, Spain.
Address correspondence and reprint requests to Dr. A. Dávalos, Department of Neurology, Hospital Universitari Doctor Josep Trueta, E-17007 Girona, Spain; e-mail: neu.adavalos{at}htrueta.scs.es
Objective: To evaluate the usefulness of a mismatch between the severity of acute clinical manifestations and the diffusion-weighted imaging (DWI) lesion in predicting early stroke outcome and infarct volume.
Methods: One hundred sixty-six patients with a hemispheric ischemic stroke of <12 hours’ duration were studied. The NIH Stroke Scale (NIHSS) score and the volume of DWI lesion were measured on admission and at 72 ± 12 hours. Infarct volume was measured on T2-weighted or fluid-attenuated inversion recovery images at day 30. Early neurologic deterioration (END) was defined as an increase of 
4 points between the two NIHSS evaluations. Thirty-eight patients received IV thrombolysis or abciximab. Clinical–DWI mismatch (CDM) was defined as NIHSS score of 8 and ischemic volume on DWI of 
25 mL on admission. The adjusted influence of CDM on END, DWI lesion enlargement at 72 hours, and infarct growth at day 30 was evaluated by logistic regression analysis and generalized linear models.
Results: CDM was found in 87 patients (52.4%). Patients with CDM had a higher risk of END than patients without CDM because NIHSS < 8 (odds ratio [OR], 9.0; 95% CI,1.9 to 42) or DWI lesion > 25 mL (OR, 2.0; 95% CI, 0.8 to 4.9). CDM was associated with an increase of 46 to 68 mL in the mean volume of DWI lesion enlargement and infarct growth in comparison with non-CDM. All the effects were even greater and significant in patients not treated with reperfusion therapies.
Conclusions: Acute stroke patients with an NIHSS score of 8 and DWI volume of 25 mL have a higher probability of infarct growth and early neurologic deterioration. The new concept of CDM may identify patients with tissue at risk of infarction for thrombolytic or neuroprotective drugs.
Received September 10, 2003. Accepted in final form February 13, 2004.
Presented in part at the 28th International Stroke Conference, Phoenix, AZ, February 2003.
This article has been cited by other articles:
|
|
 |
|
  M. Ebinger, T. Iwanaga, J. F. Prosser, D. A. De Silva, S. Christensen, M. Collins, M. W. Parsons, C. R. Levi, C. F. Bladin, P. A. Barber, et al. Clinical-Diffusion Mismatch and Benefit From Thrombolysis 3 to 6 Hours After Acute Stroke Stroke, July 1, 2009; 40(7): 2572 - 2574. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P.G. Kranz and J.D. Eastwood Does Diffusion-Weighted Imaging Represent the Ischemic Core? An Evidence-Based Systematic Review AJNR Am. J. Neuroradiol., June 1, 2009; 30(6): 1206 - 1212. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Janjua, A. El-Gengaihy, J. Pile-Spellman, and A.I. Qureshi Late Endovascular Revascularization in Acute Ischemic Stroke Based on Clinical-Diffusion Mismatch AJNR Am. J. Neuroradiol., May 1, 2009; 30(5): 1024 - 1027. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Lansberg, V. N. Thijs, R. Bammer, J.-M. Olivot, M. P. Marks, L. R. Wechsler, S. Kemp, and G. W. Albers The MRA-DWI Mismatch Identifies Patients With Stroke Who Are Likely to Benefit From Reperfusion Stroke, September 1, 2008; 39(9): 2491 - 2496. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Moldes, T. Sobrino, M. Millan, M. Castellanos, N. Perez de la Ossa, R. Leira, J. Serena, J. Vivancos, A. Davalos, and J. Castillo High Serum Levels of Endothelin-1 Predict Severe Cerebral Edema in Patients With Acute Ischemic Stroke Treated With t-PA Stroke, July 1, 2008; 39(7): 2006 - 2010. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Messe, S. E. Kasner, J. A. Chalela, B. Cucchiara, A. M. Demchuk, M. D. Hill, and S. Warach CT-NIHSS Mismatch Does Not Correlate With MRI Diffusion-Perfusion Mismatch Stroke, July 1, 2007; 38(7): 2079 - 2084. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Lansberg, V. N. Thijs, S. Hamilton, G. Schlaug, R. Bammer, S. Kemp, G. W. Albers, and on behalf of the DEFUSE Investigators Evaluation of the Clinical-Diffusion and Perfusion-Diffusion Mismatch Models in DEFUSE Stroke, June 1, 2007; 38(6): 1826 - 1830. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S. Kidwell and S. Warach Mismatch and Defuse: Harvesting the Riches of Multicenter Neuroimaging-Based Stroke Studies Stroke, June 1, 2007; 38(6): 1718 - 1719. [Full Text] [PDF]
|
|
|
|
|
|
D. M. Kent, M. D. Hill, R. Ruthazer, S. B. Coutts, A. M. Demchuk, I. Dzialowski, O. Wunderlich, and R. von Kummer "Clinical-CT Mismatch" and the Response to Systemic Thrombolytic Therapy in Acute Ischemic Stroke Stroke, August 1, 2005; 36(8): 1695 - 1699. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Prosser, K. Butcher, L. Allport, M. Parsons, L. MacGregor, P. Desmond, B. Tress, and S. Davis Clinical-Diffusion Mismatch Predicts the Putative Penumbra With High Specificity Stroke, August 1, 2005; 36(8): 1700 - 1704. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Reineck, S. Agarwal, and A. E. Hillis "Diffusion-clinical mismatch" is associated with potential for early recovery of aphasia Neurology, March 8, 2005; 64(5): 828 - 833. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Clinical-DWI Mismatch Tested to Identify Salvageable Ischemic Tissue Journal Watch Neurology, September 10, 2004; 2004(910): 4 - 4. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
